vs

Side-by-side financial comparison of ARGENX SE (ARGX) and C.H. Robinson (CHRW). Click either name above to swap in a different company.

C.H. Robinson is the larger business by last-quarter revenue ($3.9B vs $2.5B, roughly 1.6× ARGENX SE). ARGENX SE runs the higher net margin — 35.5% vs 3.5%, a 32.0% gap on every dollar of revenue. On growth, ARGENX SE posted the faster year-over-year revenue change (83.2% vs -6.5%). ARGENX SE produced more free cash flow last quarter ($322.4M vs $302.4M).

AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.

C.H. Robinson Worldwide, Inc. is an American transportation company that includes third-party logistics (3PL). The company offers freight transportation, transportation management, brokerage and warehousing. It offers truckload, less than truckload, air freight, intermodal, and ocean transportation.

ARGX vs CHRW — Head-to-Head

Bigger by revenue
CHRW
CHRW
1.6× larger
CHRW
$3.9B
$2.5B
ARGX
Growing faster (revenue YoY)
ARGX
ARGX
+89.7% gap
ARGX
83.2%
-6.5%
CHRW
Higher net margin
ARGX
ARGX
32.0% more per $
ARGX
35.5%
3.5%
CHRW
More free cash flow
ARGX
ARGX
$20.0M more FCF
ARGX
$322.4M
$302.4M
CHRW

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ARGX
ARGX
CHRW
CHRW
Revenue
$2.5B
$3.9B
Net Profit
$877.2M
$136.3M
Gross Margin
89.5%
Operating Margin
28.9%
4.6%
Net Margin
35.5%
3.5%
Revenue YoY
83.2%
-6.5%
Net Profit YoY
1.3%
-8.7%
EPS (diluted)
$13.25
$1.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARGX
ARGX
CHRW
CHRW
Q4 25
$2.5B
$3.9B
Q3 25
$4.1B
Q2 25
$1.8B
$4.1B
Q1 25
$4.0B
Q4 24
$1.4B
$4.2B
Q3 24
$4.6B
Q2 24
$901.9M
$4.5B
Q1 24
$4.4B
Net Profit
ARGX
ARGX
CHRW
CHRW
Q4 25
$877.2M
$136.3M
Q3 25
$163.0M
Q2 25
$414.8M
$152.5M
Q1 25
$135.3M
Q4 24
$865.6M
$149.3M
Q3 24
$97.2M
Q2 24
$-32.5M
$126.3M
Q1 24
$92.9M
Gross Margin
ARGX
ARGX
CHRW
CHRW
Q4 25
89.5%
Q3 25
Q2 25
89.2%
Q1 25
Q4 24
90.2%
Q3 24
Q2 24
89.4%
Q1 24
Operating Margin
ARGX
ARGX
CHRW
CHRW
Q4 25
28.9%
4.6%
Q3 25
5.3%
Q2 25
19.2%
5.2%
Q1 25
4.4%
Q4 24
8.7%
4.4%
Q3 24
3.9%
Q2 24
-15.4%
4.0%
Q1 24
2.9%
Net Margin
ARGX
ARGX
CHRW
CHRW
Q4 25
35.5%
3.5%
Q3 25
3.9%
Q2 25
23.4%
3.7%
Q1 25
3.3%
Q4 24
64.1%
3.6%
Q3 24
2.1%
Q2 24
-3.6%
2.8%
Q1 24
2.1%
EPS (diluted)
ARGX
ARGX
CHRW
CHRW
Q4 25
$13.25
$1.12
Q3 25
$1.34
Q2 25
$6.32
$1.26
Q1 25
$1.11
Q4 24
$13.33
$1.23
Q3 24
$0.80
Q2 24
$-0.55
$1.05
Q1 24
$0.78

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARGX
ARGX
CHRW
CHRW
Cash + ST InvestmentsLiquidity on hand
$3.5B
$160.9M
Total DebtLower is stronger
$1.1B
Stockholders' EquityBook value
$7.3B
$1.8B
Total Assets
$8.7B
$5.1B
Debt / EquityLower = less leverage
0.59×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARGX
ARGX
CHRW
CHRW
Q4 25
$3.5B
$160.9M
Q3 25
$136.8M
Q2 25
$2.1B
$156.0M
Q1 25
$129.9M
Q4 24
$1.5B
$145.8M
Q3 24
$131.7M
Q2 24
$1.4B
$113.2M
Q1 24
$121.8M
Total Debt
ARGX
ARGX
CHRW
CHRW
Q4 25
$1.1B
Q3 25
$1.2B
Q2 25
$1.4B
Q1 25
$1.4B
Q4 24
$1.4B
Q3 24
$1.6B
Q2 24
$11.0M
$1.6B
Q1 24
$1.7B
Stockholders' Equity
ARGX
ARGX
CHRW
CHRW
Q4 25
$7.3B
$1.8B
Q3 25
$1.9B
Q2 25
$6.1B
$1.8B
Q1 25
$1.7B
Q4 24
$5.5B
$1.7B
Q3 24
$1.6B
Q2 24
$4.3B
$1.5B
Q1 24
$1.4B
Total Assets
ARGX
ARGX
CHRW
CHRW
Q4 25
$8.7B
$5.1B
Q3 25
$5.2B
Q2 25
$7.2B
$5.3B
Q1 25
$5.2B
Q4 24
$6.2B
$5.3B
Q3 24
$5.6B
Q2 24
$4.8B
$5.5B
Q1 24
$5.5B
Debt / Equity
ARGX
ARGX
CHRW
CHRW
Q4 25
0.59×
Q3 25
0.64×
Q2 25
0.76×
Q1 25
0.80×
Q4 24
0.80×
Q3 24
0.95×
Q2 24
0.00×
1.07×
Q1 24
1.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARGX
ARGX
CHRW
CHRW
Operating Cash FlowLast quarter
$323.3M
$305.4M
Free Cash FlowOCF − Capex
$322.4M
$302.4M
FCF MarginFCF / Revenue
13.0%
7.7%
Capex IntensityCapex / Revenue
0.0%
0.1%
Cash ConversionOCF / Net Profit
0.37×
2.24×
TTM Free Cash FlowTrailing 4 quarters
$594.5M
$894.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARGX
ARGX
CHRW
CHRW
Q4 25
$323.3M
$305.4M
Q3 25
$275.4M
Q2 25
$361.8M
$227.1M
Q1 25
$106.5M
Q4 24
$41.9M
$267.9M
Q3 24
$108.1M
Q2 24
$-124.7M
$166.4M
Q1 24
$-33.3M
Free Cash Flow
ARGX
ARGX
CHRW
CHRW
Q4 25
$322.4M
$302.4M
Q3 25
$269.5M
Q2 25
$356.6M
$219.8M
Q1 25
$103.2M
Q4 24
$40.9M
$265.3M
Q3 24
$103.3M
Q2 24
$-125.5M
$159.8M
Q1 24
$-41.9M
FCF Margin
ARGX
ARGX
CHRW
CHRW
Q4 25
13.0%
7.7%
Q3 25
6.5%
Q2 25
20.1%
5.3%
Q1 25
2.5%
Q4 24
3.0%
6.3%
Q3 24
2.2%
Q2 24
-13.9%
3.6%
Q1 24
-1.0%
Capex Intensity
ARGX
ARGX
CHRW
CHRW
Q4 25
0.0%
0.1%
Q3 25
0.1%
Q2 25
0.3%
0.2%
Q1 25
0.1%
Q4 24
0.1%
0.1%
Q3 24
0.1%
Q2 24
0.1%
0.1%
Q1 24
0.2%
Cash Conversion
ARGX
ARGX
CHRW
CHRW
Q4 25
0.37×
2.24×
Q3 25
1.69×
Q2 25
0.87×
1.49×
Q1 25
0.79×
Q4 24
0.05×
1.79×
Q3 24
1.11×
Q2 24
1.32×
Q1 24
-0.36×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARGX
ARGX

Segment breakdown not available.

CHRW
CHRW

North American Service Transportation NAST$2.8B72%
Global Forwarding$731.0M19%
Sourcing$340.9M9%

Related Comparisons